PCRX Competitors & Alternatives

Compare Pacira BioSciences, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

PCRX

Main Stock
$22.32
Tradestie Score
48
Market Cap
$1.14B
P/E Ratio
171.2
Revenue Growth
0.1%
Analyst Upside
+31.2%

Top Competitors

43 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$13.20
$1.49B - 55 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 62 Compare
EVO Evotec SE American Depositary Shares
$2.89
$1.34B - 58 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$5.89
$1.29B 85.7 58 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$18.12
$1.25B 11.1 54 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$31.06
$1.11B 14.8 57 Compare
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 59 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$27.61
$543.32M - 48 Compare

Data updated: Jun 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

43 stocks in this industry